Randomized Controlled Trial of Restrictive Fluid Management in Transient Tachypnea of the Newborn - 08/12/11
![](/templates/common/images/mail.png)
![](/templates/common/images/entites/lowast.gif)
Abstract |
Objective |
To determine the effect of mild fluid restriction on the hospital course of neonates with transient tachypnea of the newborn (TTN).
Study design |
In this pilot prospective randomized controlled trial of 64 late preterm and term neonates diagnosed with TTN at a single tertiary care hospital in the United States, patients were randomized to receive standard fluid management or mild fluid restriction. The primary outcome was duration of respiratory support. Secondary outcomes were duration of admission to the intensive care unit, time to first enteral feed, and total and composite hospital costs. Results were analyzed by t-test, χ2 test, Kaplan-Meier estimation, and proportional hazards regression.
Results |
Fluid restriction did not cause adverse events or unsafe dehydration. Fluid management strategy did not affect primary or secondary outcomes in the total study population. Fluid restriction significantly reduced the duration of respiratory support (P = .008) and hospitalization costs (P = .017) in neonates with severe TTN.
Conclusion |
Mild fluid restriction appears to be safe in late preterm and term neonates with uncomplicated TTN. Fluid restriction may be of benefit in decreasing the duration of respiratory support and reducing hospitalization costs in term and late preterm neonates with uncomplicated severe TTN.
Le texte complet de cet article est disponible en PDF.Mots-clés : BUN, CPAP, DOL, GA, HFNCPAP, IV, NC, NICU, TTN
Plan
Supported by National Institutes of Health Grants 5KL2RR029885 (to A.S.). The authors declare no conflicts of interest. |
|
Study was registered with ClinicalTrials.gov: NCT01225029. |
Vol 160 - N° 1
P. 38 - janvier 2012 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?